Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Salmi, A.
Right arrow Articles by Rutanen, E.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salmi, A.
Right arrow Articles by Rutanen, E.-M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction Vol. 2, NUMBER 12 pp. 979-984, 1996
© European Society of Human Reproduction and Embryology 1996


research-article

Proto-oncogenes c-jun and c-fos are down-regulated in human endometrium during pregnancy: relationship to oestrogen receptor status

Anna Salmi1, Martti Ämmälä and Eeva-Marja Rutanen

Department of Obstetrics and Gynaecology, Helsinki University Central Hospital Finland

To whom correspondence should be addressed at: 1To whom correspondence should be addressed at: The Research Laboratory of the Department of Obstetrics and Gynaecology, Helsinki University Central Hospital (Haartmaninkatu 2). FIN-00290, Helsinki, Finland

Oestrogen is the major stimulatory factor in endometrial cell proliferation. Animal and in-vitro studies have shown that proto-oncogenes c-fos and c-jun are regulated by oestrogen receptor (ER) complex. We have previously shown by Northern blot analysis that proto-oncogenes c-fos and c-jun are strongly expressed in human proliferative and early to mid-secretory endometrium. In this study, we examined the expression of the messenger RNA (mRNA) of the nuclear proto-oncogenes c-fos and c-jun in 10 early (6–10 weeks) and 20 term (30–40 weeks) pregnancy decidua by Northern blotting. In order to investigate the relationship between ER and these proto-oncogenes, the ER and progesterone receptors (PR) were identified in the same tissue samples by immunohistochemistry. When using 30-mer oligonucleotide probes, hardly any signals for c-fos and c-jun could be identified either in early or in late pregnancy decidua. Nuclear ER staining was intense in the epithelium and stroma of proliferative and early to mid-secretory endometrium but was sparsely scattered in stroma and lacking in epithelium during early pregnancy. In late pregnancy decidua, no positive ER staining was detectable. PR were present in abundance both in endometrial epithelium and stroma in proliferative and early secretory phase, and clear positive staining remained in stromal cells in late secretory phase and throughout pregnancy. The temporal association between immunoreactive ERs and the expression of c-fos and c-jun mRNA suggests that the activation of both proto-oncogenes is ER-mediated in human endometrium. The down-regulation of ER is one possible explanation for the repression of these immediate early genes during pregnancy.

c-fos/c-jun/decidua/oestrogen receptor


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol PatholHome page
Z. A. Radi and N. K. Khan
Comparative Expression and Distribution of c-fos, Estrogen Receptor{alpha} (ER{alpha}), and p38{alpha} in the Uterus of Rats, Monkeys, and Humans
Toxicol Pathol, June 1, 2006; 34(4): 327 - 335.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
T. E. Curry Jr. and K. G. Osteen
The Matrix Metalloproteinase System: Changes, Regulation, and Impact throughout the Ovarian and Uterine Reproductive Cycle
Endocr. Rev., August 1, 2003; 24(4): 428 - 465.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. Watanabe, C. A. Kessler, C. J. Bachurski, Y. Kanda, B. D. Richardson, J. Stanek, S. Handwerger, and A. K. Brar
Identification of a Decidua-Specific Enhancer on the Human Prolactin Gene with Two Critical Activator Protein 1 (AP-1) Binding Sites
Mol. Endocrinol., April 1, 2001; 15(4): 638 - 653.
[Abstract] [Full Text]


Home page
Mol Hum ReprodHome page
S. Dhara, P.G.L. Lalitkumar, J. Sengupta, and D. Ghosh
Immunohistochemical localization of insulin-like growth factors I and II at the primary implantation site in the Rhesus monkey
Mol. Hum. Reprod., April 1, 2001; 7(4): 365 - 371.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
R. Hurskainen, A. Salmi, J. Paavonen, J. Teperi, and E.-M. Rutanen
Expression of sex steroid receptors and Ki-67 in the endometria of menorrhagic women: effects of intrauterine levonorgestrel
Mol. Hum. Reprod., November 1, 2000; 6(11): 1013 - 1018.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Liu, J. A. Schwartz, and S. C. Brooks
Estrogen Receptor Protects p53 from Deactivation by Human Double Minute-2
Cancer Res., April 1, 2000; 60(7): 1810 - 1814.
[Abstract] [Full Text]


Home page
Mol Hum ReprodHome page
S.M. Quenby, M.R. Gazvani, C. Brazeau, J. Neilson, D.I. Lewis-Jones, and G. Vince
Oncogenes and tumour suppressor genes in first trimester human fetal gonadal development
Mol. Hum. Reprod., August 1, 1999; 5(8): 737 - 741.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D. Ghosh, S. Dhara, A. Kumar, and J. Sengupta
Immunohistochemical localization of receptors for progesterone and oestradiol-17{beta} in the implantation site of the rhesus monkey
Hum. Reprod., February 1, 1999; 14(2): 505 - 514.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Salmi, P. Heikkilä, S. Lintula, and E.-M. Rutanen
Cellular Localization of c-Jun Messenger Ribonucleic Acid and Protein and Their Relation to the Proliferation Marker Ki-67 in the Human Endometrium
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1788 - 1796.
[Abstract] [Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.